Skip to main content
logo
Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
4.470
+0.010 (0.22%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Silo Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5544110
Market Cap Growth
56.37%13.46%-4.63%-60.57%3662.33%-
Enterprise Value
-1.18-2.55-3.09-3.48-0.76-9.97
Last Close Price
4.475.1013.3521.6050.402.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----0.10
PS Ratio
67.2362.8055.3558.04147.203.96
PB Ratio
0.850.720.790.681.030.03
P/TBV Ratio
0.580.470.680.720.740.03

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--35.40-42.85-48.27-10.49-139.97
EV/EBITDA Ratio
-0.600.660.900.213.63
EV/EBIT Ratio
-0.600.660.900.213.63
EV/FCF Ratio
-0.550.811.080.224.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.09-1.12-1.41-1.24-1.10-1.13
Net Debt / EBITDA Ratio
1.301.661.511.993.133.74
Net Debt / FCF Ratio
1.621.521.852.383.254.50
Asset Turnover
0.010.010.010.010.010.01
Quick Ratio
8.8010.894.289.8826.2120.93
Current Ratio
9.6511.364.299.9026.5221.23
Return on Equity (ROE)
-80.81%-74.56%-78.37%-43.97%-77.67%27.32%
Return on Assets (ROA)
-65.39%-57.01%-62.09%-39.77%-32.78%-45.78%
Return on Capital Employed (ROCE)
-72.07%-67.35%-73.95%-42.42%-34.21%-48.64%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-----1000.00%
Buyback Yield / Dilution
-161.67%-127.76%-19.50%-34.83%-19.07%-45.44%
Total Shareholder Return
-161.67%-127.76%-19.50%-34.83%-19.07%-45.44%
SEC Filings: 10-K · 10-Q